Amanda Liszewski, PharmD
Dr. Liszewski is a graduate of the Duquesne University Mylan School of Pharmacy in Pittsburgh, Pennsylvania, where she earned her PharmD degree in 2013. Her current areas of interest are critical care and solid organ transplant. Dr. Liszewski’s internal quality project will assess the adherence to insulin protocols for treatment of patients with diabetic ketoacidosis and hyperosmolar hyperglycemic state in the emergency department. Her longitudinal research project will evaluate differences in blood glucose control and other clinical outcomes between patients with septic shock who received hydrocortisone as intermittent bolus doses and those who received hydrocortisone as a continuous infusion. Upon completion of the PGY1-Pharmacy Residency, she plans to pursue a PGY-2 critical care residency within a tertiary care academic medical center. Outside of work, her interests include music, running and Pittsburgh sports.
Lia Lynch, PharmD
Dr. Lynch is a graduate of the University of North Carolina Eshelman School of Pharmacy in Chapel Hill, North Carolina, where she earned her PharmD in 2013. Her professional interests are hematology/oncology and infectious disease, and upon completion of the PGY1 program she plans to pursue a PGY2 position in hematology/oncology. Lia will complete a quality improvement project evaluating the use of brentuximab, carfilzomib, and paclitaxel albumin-bound within the University of Virginia Health System and affiliated HOPE clinics. Her longitudinal research project will assess heparin dosing in obese patients. Outside of her time spent in the hospital, Lia enjoys spending time with her husband cheering on her favorite team, the NC State Wolfpack, wine tasting in the Virginia countryside, and baking.
Laura Mincemoyer, PharmD
Dr. Mincemoyer is a graduate of the University of Pittsburgh School of Pharmacy in Pittsburgh, Pennsylvania, where she earned her PharmD degree in 2013. Her current areas of interest include solid organ transplantation and critical care. Dr. Mincemoyer’s medication use evaluation will assess appropriate utilization of the UVaHS nurse driven heparin nomogram for treatment of patients diagnosed with acute coronary syndromes and arterial or venous thromboembolism in the Emergency Department. Her longitudinal research project will evaluate the efficacy of the institution’s Labor and Delivery insulin infusion protocol and associated rates of neonatal hypoglycemia. Upon completion of the PGY-1 pharmacy residency, she plans to pursue a PGY-2 residency or clinical pharmacist position at a tertiary care academic medical center. In her spare time, Dr. Mincemoyer enjoys reading, baking, and cheering on her Penn State Nittany Lion football team!
Amy Morris, PharmD
Dr. Morris is a 2013 graduate of the University of Georgia College of Pharmacy in Athens, Georgia. Her current areas of interest include oncology and infectious disease in immunocompromised hosts. Amy’s medication use evaluation will assess the use of the new oral anticoagulant rivaroxaban (Xarelto) in oncology patients. Her research project will evaluate the relationship between immune-mediated dermatitis and outcomes in patients treated with ipilimumab (Yervoy) for metastatic melanoma. Upon completion of the PGY-1 pharmacy residency, she plans to pursue a PGY-2 oncology residency at an academic medical center. Amy’s interests outside of pharmacy include horseback riding, running, and trying all the amazing restaurants that Charlottesville has to offer.
Karen Partlow, PharmD
Dr. Partlow is excited to be back in Charlottesville where she received her undergraduate degrees in Biochemistry and Sociology from the University of Virginia. After spending five years as a reimbursement consultant, she returned to school and earned her PharmD from the University of Maryland. Her professional interests are critical care and infectious disease. Dr. Partlow will complete a medication use evaluation to determine the impact of a systemic inflammatory response syndrome (SIRS) best practice alert on identifying septic patients and facilitating early and appropriate goal-directed therapy and antimicrobial selection. Her longitudinal research project will examine 30-day medication related readmissions. Upon completion of her PGY-1 pharmacy residency, she plans to pursue a PGY-2 critical care residency. Outside of work she enjoys watching sports (Go Nats and Caps!), cooking, and chasing chipmunks with her beagle Hootie.
System Pharmacy Administration Resident
Thomas DiPiro, PharmD, MBA
Dr. DiPiro is a graduate of the South Carolina College of Pharmacy at the Medical University of South Carolina campus, where he earned his PharmD in 2013. He is also a graduate of The Citadel, where he completed his MBA in 2012. His current professional interests include pediatrics and emergency medicine. Outside of the hospital he follows college football, and roots for the Georgia Bulldogs on Saturdays. He will be completing a quality improvement project assessing adherence to the immune globulin (IVIG) guideline at the University of Virginia Health System. During his two years at UVa he will also complete a Masters in Health System Pharmacy Administration from Virginia Commonwealth University School of Pharmacy.
PGY1-Pharmacy/PGY2-Health System Pharmacy Administration
Michael Bedenbaugh, PharmD, MBA
Dr. Bedenbaugh is a graduate of the South Carolina College of Pharmacy in Columbia, South Carolina, where he completed both his PharmD and MBA in 2012. He completed the first year of the newly combined two-year residency plus Master’s program at UVA last year and looks forward to the upcoming year in Charlottesville. He will be working to complete a quality project that will evaluate medication overrides from automated dispensing cabinets. His longitudinal project will assess the impact of various cost control strategies on the overall pharmaceutical expenditures at the organization. Additionally, he will continue to complete coursework at the Virginia Commonwealth University School of Pharmacy. In his spare time, Michael enjoys following Wall Street and college athletics, particularly the Clemson Tigers.
J. Nate Hedrick, PharmD
Dr. Hedrick is a graduate of the University of North Carolina Eshelman School of Pharmacy in Chapel Hill, North Carolina, where he earned his PharmD degree in 2012. He completed his PGY1-Pharmacy Residency at the University of Virginia Health System. Dr. Hedrick will complete a medication use evaluation to determine whether alteplase is being used appropriately according to institutional guidelines during cardiac arrest events, and outcomes associated with its use. His longitudinal research project will evaluate the appropriateness of antimicrobial selection upon referring hospital transfer to the medical intensive care unit. Upon completion of the PGY2-Critical Care pharmacy residency, he plans to pursue a position as a critical care clinical pharmacist at a large medical center. Outside of work, he enjoys cooking, reading, woodworking and the outdoors.
Kelly Gaertner, PharmD
Dr. Gaertner is a 2011 graduate of Duquesne University in Pittsburgh, PA. She completed both a PGY1 residency at Riverside Methodist Hospital and a community practice residency at Allegheny General Hospital. Within hematology/oncology, her interest includes solid tumors and supportive care, but is excited to gain more experience in malignant hematology. She is completing a quality project assessing sepsis alerts in the neutropenic population. Her longitudinal research project will focus on evaluating guideline-driven supplemental gram positive antibiotic coverage for febrile neutropenia. Upon completion of her PGY2 residency, she plans to pursue a career at an outpatient oncology clinic or an academic medical center, with opportunities to teach.
Organ Transplant Resident
Michelle Hurrell Bradley, PharmD
Dr. Bradley is a graduate of the Mercer University College of Pharmacy and Health Sciences in Atlanta, Georgia, where she earned her PharmD degree in 2011. She completed her PGY1 at the University of Alabama at Birmingham (UAB) Hospital. Her current areas of interest include solid organ transplant and infectious diseases within the SOT population. Dr. Bradley's longitudinal residency project will evaluate adherence to and outcomes associated with the newly implemented risk stratified immunosuppression regimen in renal transplant patients at UVaHS. Her medication use evaluation will evaluate the use of thymoglobulin within the institution. In her free time, Dr. Bradley enjoys playing with her two cats and seeing movies. Upon completion of the PGY-2 Solid Organ Transplant pharmacy residency, Dr. Bradley hopes to obtain a specialist position in transplantation with the opportunity to precept residents and PharmD students.
Terran Rice, PharmD
Dr. Rice is a graduate of University of the Pacific Thomas J. Long School of Pharmacy and Health Sciences in California, where he earned his PharmD in May 2011. Upon completion of his studies, he practiced as a staff pharmacist for CVS/Pharmacy for a year then proceeded to a PGY-1 Pharmacy Residency at York Hospital in Pennsylvania. His current areas of interest include data analysis, data warehousing, and the application of technology to allow more efficient workflow. Outside of pharmacy his hobbies include cooking and computers. He will complete a medication use to evaluate the impact of alternative medication alerts for medications on shortage. His longitudinal research project will evaluate the impact of a process change on the practice of pharmacy. Upon completion of a PGY-2 in pharmacy informatics, he wishes to pursue a career as a pharmacist informaticist.